Study: Roflumilast cream 0.05% is safe, effective in young children with eczema

Once-daily roflumilast cream 0.05% is safe and effective for atopic dermatitis (AD) in patients ages 2 to 5 years, according to a study published online Feb. 20 in Pediatric Dermatology.

Leave A Comment

Your email address will not be published. Required fields are marked *